arrow
H

Hiroshi Yotsuyanagi

the university of tokyo
H指数:51
被引数:9,382

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

代谢功能障碍相关脂肪性肝病(MASLD)2026年循证临床实践指南

2026-05-120
OAAI
Assessment of cellular and humoral immunity against varicella-zoster virus in adult allogeneic hematopoietic cell transplant recipients: a cross-sectional study assessing cellular immunity after administration of an adjuvanted recombinant zoster vaccine

评估成人异基因造血细胞移植受者对水痘-带状疱疹病毒的细胞和体液免疫:一项评估加佐剂重组带状疱疹疫苗给药后细胞免疫的横断面研究

2025-11-010
PRE
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs ex vivo

EZH1/2双抑制剂valemetostat在体外重新激活潜伏HIV-1储库方面优于EZH2选择性抑制剂。

2025-04-100
OA
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial

Ensetrelvir治疗无症状或轻度新型冠状病毒肺炎的疗效和安全性: 一项多中心、随机、2b/3期临床试验的探索性分析

2024-06-180
OAAI
Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study

HIV/HCV合并感染导致的血友病和肝硬化患者OP-724的安全性和耐受性: 研究者发起的,开放标签,非随机,单中心,I期研究

2024-04-270
OAAI